Replies to post #106112 on Amarin Corp Plc (AMRN)

[rafunrafun]

Wow, better than I thought. Nice to see that we're already averaging roughly what is needed to average FOR THE YEAR to reach the $150M, and of course the scripts are rising nearly every week.

To reach the top end of projections ($165M), we would need to average 24,534/w until until EOY (34 weeks).

To reach the bottom end of projections ($150M), we would need to average 21,278/w until until EOY.

What are your projections, if RI continues / stops?

Thank you.

[talleyville0311]

So in a couple more weeks we should be on par or above par for 165m? We are looking fantastic if this is right!!

[irc203]

Per one of the brokerage firms, AMRN raised the price of Vascepa 9% on 12/16/17, if memory serves me correctly.

Per John Thero first qtr conference call: "We continue to view this as a volume growth business. ...that expanded coverage eats a little bit into the gross and that we are continuing to see more co-pay cards used..."

How much of the price concession for the expanded improved insurance coverage will be covered by the price increase? How much is a little bit?

Will prior correlations between scripts and revenues need to be adjusted for the improved and expanded coverage and the 9% price increase? The price increase in December 2016 was 6%.